Pathophysiology and Treatment of the No-Reflow Phenomenon in ST-Segment Elevation Myocardial Infarction: Focus on Low-Dose Fibrinolysis during Primary Percutaneous Intervention.

ST-elevation myocardial infarction infarct-related artery microvascular obstruction no reflow percutaneous coronary intervention

Journal

Reviews in cardiovascular medicine
ISSN: 1530-6550
Titre abrégé: Rev Cardiovasc Med
Pays: Singapore
ID NLM: 100960007

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 28 05 2023
revised: 12 07 2023
accepted: 01 08 2023
medline: 30 7 2024
pubmed: 30 7 2024
entrez: 30 7 2024
Statut: epublish

Résumé

Primary percutaneous coronary intervention (PCI) is the current class I therapeutic approach to treat acute ST-elevation myocardial infarction (STEMI). While primary PCI can restore adequate flow in the infarcted artery in the majority of cases, some patients experience the 'no-reflow' phenomenon, i.e., an abnormal myocardial reperfusion occurring even after the occluded coronary artery has been opened. No-reflow occurs when microvascular obstruction arises from embolization of thrombus or components of the atheromatous plaques. These embolic materials travel downstream within the infarct-related artery at time of primary PCI, leading to compromised blood flow. Currently, no expert consensus documents exist to outline an optimal strategy to prevent or treat no-reflow. Interventional cardiologists frequently employ intracoronary adenosine, calcium channel blockers, nicorandil, nitroprusside or glycoprotein IIb/IIIa inhibitors. However, evidence suggests that these interventions consistently enhance myocardial blood flow in only a specific subset of patients experiencing no-reflow. A recent and innovative therapeutic approach gaining attention is low-dose fibrinolysis during primary PCI, which offers the potential to augment coronary flow post-myocardial revascularization.

Identifiants

pubmed: 39077094
doi: 10.31083/j.rcm2412365
pii: S1530-6550(23)01100-6
pmc: PMC11272854
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

365

Informations de copyright

Copyright: © 2023 The Author(s). Published by IMR Press.

Déclaration de conflit d'intérêts

The author declares no conflict of interest. Francesco Pelliccia and Salvatore De Rosa are serving as one of the Editorial Board members and Guest editors of this journal. Marco Zimarino is serving as one of the Editorial Board members of this journal. Giuseppe Andò and Ciro Indolfi are serving as one of the Guest editors of this journal. We declare that Francesco Pelliccia, Marco Zimarino, Giuseppe Andò, Salvatore De Rosa and Ciro Indolfi had no involvement in the peer review of this article and have no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to Giuseppe Boriani.

Auteurs

Francesco Pelliccia (F)

Department of Cardiovascular Sciences, University Sapienza, 00185 Rome, Italy.

Giampaolo Niccoli (G)

Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.

Marco Zimarino (M)

Department of Neuroscience, Imaging and Clinical Sciences, 'G. D'Annunzio' University of Chieti-Pescara, 66100 Chieti, Italy.

Giuseppe Andò (G)

Department of Clinical and Experimental Medicine, University of Messina, 98124 Messina, Italy.

Italo Porto (I)

Department of Internal Medicine and Specialties, University of Genoa, 16132 Genova, Italy.
Cardiology Unit, Cardiothoracic and Vascular Department (DICATOV) IRCCS, Ospedale Policlinico San Martino, 16132 Genoa, Italy.

Paolo Calabrò (P)

Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", 81100 Caserta, Italy.
Division of Clinical Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", 81100 Caserta, Italy.

Salvatore De Rosa (S)

Division of Cardiology, Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy.

Felice Gragnano (F)

Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", 81100 Caserta, Italy.
Division of Clinical Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", 81100 Caserta, Italy.

Raffaele Piccolo (R)

Department of Advanced Biomedical Sciences, University of Naples Federico II, 80131 Naples, Italy.

Elisabetta Moscarella (E)

Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", 81100 Caserta, Italy.
Division of Clinical Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", 81100 Caserta, Italy.

Enrico Fabris (E)

Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, 34148 Trieste, Italy.

Rocco Antonio Montone (RA)

Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Carmen Spaccarotella (C)

Division of Cardiology, Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy.

Ciro Indolfi (C)

Division of Cardiology, Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy.

Gianfranco Sinagra (G)

Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, 34148 Trieste, Italy.

Pasquale Perrone Filardi (PP)

Department of Advanced Biomedical Sciences, University of Naples Federico II, 80131 Naples, Italy.

Classifications MeSH